Skip to content

Safety and Efficacy of Epicardial Radiofrequency Ablation for Ventricular Arrhythmias - A Multicenter Clinical Registry Study

Safety and Efficacy of Epicardial Radiofrequency Ablation for Ventricular Arrhythmias - A Multicenter Clinical Registry Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102163
Enrollment
Unknown
Registered
2025-05-09
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular arrhythmias

Interventions

Observation group:None

Sponsors

Suzhou Kowloon Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 80 years old; 2. Patients with arrhythmias who are candidates for epicardial radiofrequency ablation; 3. Patients who are refractory to or intolerant of at least one Class I/III antiarrhythmic drug (AAD); 4. Patients who have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Non-epicardial ventricular arrhythmias; 2. Pregnancy or lactation; 3. The expected survival time is less than 1 year (such as end-stage heart failure, malignant tumors) 4. Unable to complete follow-up;

Design outcomes

Primary

MeasureTime frame
Success rate;Safety endpoint;

Secondary

MeasureTime frame
The impact of ablation techniques and ablation energy on therapeutic efficacy, etc;Etiological subgroup analysis (idiopathic vs. SHD);Long-term recurrence-free rate (no recurrence of VT at 1 year postoperatively);;

Countries

China

Contacts

Public ContactYou Bingquan

Suzhou Kowloon Hospital

youbingquan@126.com+86 13771990907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026